Novartis completes influenza vaccine business divestiture to CSL Limited

Novartis announced today that it has finished its divestiture of the company’s influenza vaccine unit to another company, CSL Limited, for $275 million (USD). Read More »

BiondVax universal flu vaccine shows positive independent results

BiondVax Pharmaceuticals Ltd. recently announced that the independent results of its universal flu vaccine (M-001) show effective immunogenicity against H3N2. Read More »

Public Health England expects new meningococcal vaccination program to save lives

Public Health England (PHE) recently announced that it expects the new MenACWY vaccination program, which is designed to protect teenagers from sepitcaemiea (blood poisoning) and meningitis (brain inflammation), to save lives. Read More »

New Ebola vaccine trial 100 percent effective

According to a recent report from The Guardian, an Ebola vaccine trial that took place in Guinea and involved 4,000 people is considered 100 percent effective in protecting people against Ebola. Read More »

Washington's Salmonella outbreak increases to 90 cases

The recent outbreak of Salmonella infections, which may be connected to pork products, has now spread to 90 cases throughout Washington State. Read More »

UC Davis scientists make headway in HIV fight

A team of scientists at UC Davis recently identified a specific compound that wakes up latent human immunodeficiency virus (HIV) in order to tease the virus out of hiding and then destroy it. Read More »

USDA unveils conservation incentives for farmers, ranchers

U.S. Agriculture Secretary Tom Vilsack said on Monday that beginning on Sept. 1, farmers and ranchers can apply for financial assistance to help conserve their working grasslands, rangeland and pastureland while maintaining the areas as livestock grazing lands. Read More »

Data shows low HPV vaccination rates among Alabama teens

The Alabama Department of Public Health recently received data that shows that there are significantly low rates of HPV vaccinations among teens living in Alabama. Read More »

Virus-like nanoparticle vaccine effective against RSV

A team of researchers from Georgia State University recently conducted a study showing that a vaccine with virus-like nanoparticles is an effective treatment for patients with respiratory syncytial virus (RSV). Read More »

Partnership expands to create mRNA vaccines

CureVac, a clinical-stage biopharmaceutical company that is pioneering the field of mRNA-based technology, said Tuesday it has launched its third target product development program in collaboration with the Bill & Melinda Gates Foundation. Read More »

Converging approaches hold promise for effective HIV vaccine

Two experts from the National Institutes of Health say different scientific approaches are uniting to advance the urgent, ongoing search for an effective vaccine against the global HIV pandemic. Read More »

First malaria vaccine for infants and children moves forward

Scientists from New York University’s Langone Medical Center have developed a new malaria vaccine that recently received an approval recommendation from the European Medicines Agency to be the world’s first licensed vaccine to protect infants and children from the disease. Read More »

Mississippi reports third West Nile virus case in 2015

The Mississippi Department of Health recently confirmed that the state has had its third human case of West Nile virus for 2015. Read More »

Over 287,000 children vaccinated for measles in the Democratic Republic of the Congo

Medecins Sans Frontieres (MSF), or Doctors Without Borders, recently announced that it has successfully vaccinated more than 287,000 children for measles in the Democratic Republic of the Congo (DRC) since March. Read More »

Australia grants Zoetis' new Hendra virus vaccine full registration

Zoetis recently announced that the Australia Pesticides and Veterinary Medicines Authority (APVMA) has granted full registration for Equivac HeV, a vaccine for the Hendra virus. Read More »

Arrowhead to present at Jefferies 2015 Hepatitis B Summit

Arrowhead Research Corporation recently announced that Bruce Given, the company’s chief operating officer and the head of its research and development department, will represent the company in a presentation at the Jefferies 2015 Hepatitis B Summit. Read More »

Mumps cases continue to spread in Illinois

Health professionals recently confirmed that there have been additional new cases of mumps at the University of Illinois, Urbana-Champaign. Read More »

CDC models drug-resistant infections and C. difficile growth

The most recent Centers for Disease Control and Prevention (CDC) Vital Signs shows a mathematical model that is designed to demonstrate the rise in Clostridium difficile (C. difficile) and drug-resistant infections. Read More »

California health officer warns public about Valley Fever

California Department of Public Health (CDPH) Director and State Health Officer Dr. Karen Smith recently warned residents of California to be cautious of Valley Fever, which is a potentially fatal infectious disease. Read More »

CDC funding to address infectious disease threats

Local communities and states to share nearly $110 million to help prevent and track disease outbreaks. Read More »